Pouria Sanae
CEO
ixlayer
The Benefits of At-Home Lab Testing
Pouria Sanae, CEO & co-founder of ixlayer, a digital health company, is at the forefront of large-scale diagnostic testing. Seventy percent of today’s medical decisions depend on laboratory test results. These tests provide doctors and patients with thorough information they need. Yet, statistics show over 40% of clinical lab test orders go unfilled—leaving many individuals undiagnosed and untreated.
According to the American Hospital Association, nearly 50% of Americans have a chronic condition that requires ongoing lab tests. Delayed diagnoses, undertreatment, and non-adherence are pervasive and deadly problems for the entire healthcare system. Experts estimate that non-adherence contributes to up to half of all treatment failures, a quarter of hospitalizations, and 125,000 avoidable deaths every year.
Pouria sees this gap and challenge as an opportunity for pharmaceutical companies looking to evolve their role in the healthcare ecosystem. Over the past few years, he and his team have developed a platform that enables pharma to overcome regulatory and infrastructure hurdles that often stand in the way of expanding into the diagnostics space.
“Pouria sees the gap and challenge as an opportunity for pharmaceutical companies looking to evolve their role in the healthcare ecosystem.”
Lab testing requires complex and costly logistics. Instead of reinventing the process for each new lab testing offering, ixlayer provides the infrastructure to enable trusted brands to launch accessible, convenient, and configurable health testing programs. Ixlayer provides everything partners need to orchestrate at-home testing from start to finish. This includes thousands of custom diagnostic kits and connections to a vast network of CAP-accredited and CLIA-certified labs.
The platform also enables patient education, contextualized lab results, remote patient monitoring, and personalized calls to action to ensure patients understand their condition and actively engage in their own care.
Convenient, at-home diagnostic testing options create opportunities to enhance patients’ healthcare. Through at-home testing, pharma companies can make certain their products are reaching the right
populations. Pouria and his team are proud of their results. To date, over four million tests have been ordered across 1,100 nationwide programs.